US3361306A
(en)
|
1966-03-31 |
1968-01-02 |
Merck & Co Inc |
Aerosol unit dispensing uniform amounts of a medically active ingredient
|
US3565070A
(en)
|
1969-02-28 |
1971-02-23 |
Riker Laboratories Inc |
Inhalation actuable aerosol dispenser
|
FR2224175B1
(es)
|
1973-04-04 |
1978-04-14 |
Isf Spa |
|
US4069819A
(en)
|
1973-04-13 |
1978-01-24 |
Societa Farmaceutici S.P.A. |
Inhalation device
|
IT1017153B
(it)
|
1974-07-15 |
1977-07-20 |
Isf Spa |
Apparecchio per inalazioni
|
NL7606413A
(en)
|
1976-06-14 |
1977-12-16 |
Kowa Co |
Adenosine-5'-phosphoric acid derivs. and their salts - prepd. by acylating adenosine-5'-phosphate and opt. desalting or salt exchanging
|
DE2626792A1
(de)
|
1976-06-15 |
1977-12-29 |
Kowa Co |
Acylderivate von adenosin-5'-monophosphorsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
|
FR2354774A1
(fr)
|
1976-06-15 |
1978-01-13 |
Kowa Co |
Derives de l'acide adenosine-5'-monophosphorique et medicament contenant ces substances
|
SE438261B
(sv)
|
1981-07-08 |
1985-04-15 |
Draco Ab |
Anvendning i dosinhalator av ett perforerat membran
|
US4805811A
(en)
|
1985-03-29 |
1989-02-21 |
Aktiebolaget Draco |
Dosage device
|
SE448277B
(sv)
|
1985-04-12 |
1987-02-09 |
Draco Ab |
Indikeringsanordning vid en doseringsanordning for lekemedel
|
JPS6286363A
(ja)
|
1985-10-11 |
1987-04-20 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
DE3528753A1
(de)
|
1985-08-10 |
1987-02-19 |
Bayer Ag |
Substituierte pyrazolin-5-one
|
US4707540A
(en)
|
1986-10-29 |
1987-11-17 |
Morton Thiokol, Inc. |
Nitramine oxetanes and polyethers formed therefrom
|
US4871758A
(en)
|
1987-03-18 |
1989-10-03 |
Schulman Jerome M |
Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
|
DE3711345A1
(de)
|
1987-04-03 |
1988-10-20 |
Bayer Ag |
Substituierte propylamine
|
IN167775B
(es)
|
1988-06-24 |
1990-12-22 |
Hoechst India |
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
US4955371A
(en)
|
1989-05-08 |
1990-09-11 |
Transtech Scientific, Inc. |
Disposable inhalation activated, aerosol device for pulmonary medicine
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
DE3932052A1
(de)
|
1989-09-26 |
1991-04-04 |
Basf Ag |
Oxazol- bzw. thiazolcarbonsaeureamide
|
EP0604409B1
(en)
|
1990-01-11 |
2004-07-14 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide analogs for detecting and modulating rna activity and gene expression
|
YU84791A
(sh)
|
1990-05-19 |
1994-06-10 |
Boehringer Ingelheim Kg. |
Biciklicni 1-aza-cikloalkalni
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
FR2669639A1
(fr)
|
1990-11-27 |
1992-05-29 |
Atochem |
Cocatalyseur de polymerisation du propylene a base de silane et de monoether.
|
TW239158B
(es)
|
1991-02-15 |
1995-01-21 |
Lubrizol Corp |
|
DE69233690T2
(de)
|
1991-07-02 |
2008-01-24 |
Nektar Therapeutics, San Carlos |
Abgabevorrichtung für nebelförmige Medikamente
|
GB9202791D0
(en)
|
1992-02-11 |
1992-03-25 |
British Bio Technology |
Compounds
|
US5261538A
(en)
|
1992-04-21 |
1993-11-16 |
Glaxo Inc. |
Aerosol testing method
|
US5785049A
(en)
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
DE4232852A1
(de)
|
1992-09-30 |
1994-03-31 |
Bayer Ag |
Imidazolinyl-pyridazine
|
US5388572A
(en)
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
DE69522494T2
(de)
|
1994-04-14 |
2002-04-25 |
Canon K.K., Tokio/Tokyo |
Flüssigkristallzusammensetzung, Anzeigevorrichtung und Verfahren diese verwendend
|
US5522385A
(en)
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US5544647A
(en)
|
1994-11-29 |
1996-08-13 |
Iep Group, Inc. |
Metered dose inhalator
|
US5622163A
(en)
|
1994-11-29 |
1997-04-22 |
Iep Group, Inc. |
Counter for fluid dispensers
|
JP3822925B2
(ja)
|
1995-07-18 |
2006-09-20 |
興和株式会社 |
2’−3’−ジ−o−アシルatpの製造法
|
JPH09328497A
(ja)
|
1996-04-12 |
1997-12-22 |
Yamasa Shoyu Co Ltd |
4’−フルオロメチルヌクレオシド
|
CZ126799A3
(cs)
|
1996-10-16 |
1999-07-14 |
Icn Pharmaceuticals |
Purinové L-nukleosidy a jejich analogy a farmaceutické prostředky, které je obsahují
|
NZ500831A
(en)
|
1997-06-30 |
2001-06-29 |
Icn Pharmaceuticals |
Method of producing tiazofurin and other C-nucleosides using a single step process wherein the cyano sugar group is converted into thiocarboxamide and subsequently condensed to form an azole ring
|
ES2242291T5
(es)
|
1997-09-12 |
2016-03-11 |
Exiqon A/S |
Análogos de nucleósidos bicíclicos y tricíclicos, nucleótidos y oligonucleótidos
|
US6150379A
(en)
|
1997-11-26 |
2000-11-21 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as anticoagulants
|
AU1608399A
(en)
|
1997-11-26 |
1999-06-15 |
Axys Pharmaceuticals, Inc. |
Substituted amidinoaryl derivatives and their use as anticoagulants
|
US5972099A
(en)
|
1997-12-17 |
1999-10-26 |
Bayer Corporation |
Process for preparing organic pigment compositions
|
CO5040088A1
(es)
|
1998-04-03 |
2001-05-29 |
Advanced Medicine Inc |
Nuevos compuestos y usos anestesicos locales
|
WO1999061583A2
(en)
|
1998-05-28 |
1999-12-02 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
US6306895B1
(en)
|
1998-07-03 |
2001-10-23 |
Millenium Pharmaceuticals, Inc. |
Substituted oxygen alicyclic compounds, including methods for synthesis thereof
|
WO2000032152A2
(en)
|
1998-12-02 |
2000-06-08 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
US6116234A
(en)
|
1999-02-01 |
2000-09-12 |
Iep Pharmaceutical Devices Inc. |
Metered dose inhaler agitator
|
GB9908934D0
(en)
|
1999-04-19 |
1999-06-16 |
Rolic Ag |
Liquid crystalline compounds
|
EP1046631A1
(en)
|
1999-04-19 |
2000-10-25 |
Rolic AG |
Liquid crystalline compounds
|
ATE356824T1
(de)
|
1999-05-04 |
2007-04-15 |
Santaris Pharma As |
L-ribo-lna analoge
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
IL147281A0
(en)
|
1999-06-29 |
2002-08-14 |
Uab Research Foundation |
Methods of treating fungal infections with inhibitors of nad synthetase enzyme
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
EP1204645A2
(en)
|
1999-08-04 |
2002-05-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
DE19939910A1
(de)
|
1999-08-23 |
2001-03-01 |
Morphochem Ag |
Neue Verbindungen, die Tryptase-Aktivität hemmen
|
EP1214332A1
(en)
|
1999-09-17 |
2002-06-19 |
Amersham Biosciences Corp. |
Charge-modified nucleic acid terminators
|
EP1218336A2
(en)
|
1999-09-20 |
2002-07-03 |
Takeda Chemical Industries, Ltd. |
Melanin concentrating hormone antagonist
|
US6514964B1
(en)
|
1999-09-27 |
2003-02-04 |
Amgen Inc. |
Fused cycloheptane and fused azacycloheptane compounds and their methods of use
|
GB9930557D0
(en)
|
1999-12-23 |
2000-02-16 |
Rolic Ag |
Optically active materials
|
EP1259485B1
(en)
|
2000-02-29 |
2005-11-30 |
Millennium Pharmaceuticals, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
US20090124690A1
(en)
|
2000-04-03 |
2009-05-14 |
Alberte Randall S |
Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
|
WO2001077091A2
(en)
|
2000-04-05 |
2001-10-18 |
Tularik Inc. |
Ns5b hcv polymerase inhibitors
|
US6696081B2
(en)
|
2000-06-09 |
2004-02-24 |
Duke University |
Carbohydrate based lipid compositions and supramolecular structures comprising same
|
EP1170353B1
(en)
|
2000-07-06 |
2005-11-02 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and aligment promoter
|
EP1301074A2
(en)
|
2000-07-14 |
2003-04-16 |
The UAB Research Foundation |
Uses for nad synthetase inhibitors
|
AU2001279955A1
(en)
|
2000-08-18 |
2002-03-04 |
Sterix Limited |
2-substituted estradiol derivative for inhibiting superoxid dismutase
|
AU2001294865A1
(en)
|
2000-09-30 |
2002-04-15 |
Loctite |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
IL155202A0
(en)
|
2000-10-20 |
2003-11-23 |
Biocryst Pharm Inc |
Biaryl compounds as serine protease inhibitors
|
AUPR105700A0
(en)
|
2000-10-27 |
2000-11-23 |
Monash University |
Process for preparation of bicyclic and polycyclic molecules
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
AUPR213700A0
(en)
|
2000-12-18 |
2001-01-25 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
EP1363890A4
(en)
|
2001-02-07 |
2009-06-10 |
Ore Pharmaceuticals Inc |
MELANOCORTIN-4-RECEPTOR BINDING COMPOUNDS AND METHOD FOR THEIR APPLICATION
|
JP2002326996A
(ja)
|
2001-03-02 |
2002-11-15 |
Toray Ind Inc |
光学活性体の製造法
|
JP4161291B2
(ja)
|
2001-03-02 |
2008-10-08 |
東レ・ファインケミカル株式会社 |
光学活性体の製造法
|
JP4342178B2
(ja)
|
2001-04-06 |
2009-10-14 |
バイオクリスト・ファマシューティカルズ インク. |
セリンプロテアーゼ阻害剤としてのビアリール化合物
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
EP1572067A4
(en)
|
2001-05-18 |
2009-05-13 |
Sirna Therapeutics Inc |
CONJUGATES AND COMPOSITIONS FOR CELL DELIVERY
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
WO2004043335A2
(en)
|
2001-09-13 |
2004-05-27 |
Genesoft, Inc. |
Methods of treating infection by drug resistant bacteria
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
WO2003041649A2
(en)
|
2001-11-13 |
2003-05-22 |
Merck Frosst Canada & Co. |
Cyanoalkylamino derivatives as protease inhibitors
|
CA2469336C
(en)
|
2001-12-11 |
2013-06-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Guanidinium transport reagents and conjugates
|
JP2003246770A
(ja)
|
2002-02-25 |
2003-09-02 |
Toray Ind Inc |
光学活性体の製造法
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
AU2003225156A1
(en)
|
2002-04-24 |
2003-11-10 |
Symyx Technologies, Inc. |
Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
|
EP1498125A4
(en)
|
2002-04-24 |
2008-08-20 |
Takeda Pharmaceutical |
USE OF ANTI-CCR ANTAGONISM COMPOUNDS
|
TW200500374A
(en)
|
2002-06-28 |
2005-01-01 |
Idenlx Cayman Ltd |
2' and 3' -nucleoside produrgs for treating flavivridae infections
|
US20060004010A1
(en)
|
2002-07-10 |
2006-01-05 |
Hiromu Habashita |
Ccr4 antagonist and medical use thereof
|
WO2004014312A2
(en)
|
2002-08-08 |
2004-02-19 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
US20040146941A1
(en)
|
2002-11-04 |
2004-07-29 |
Biliang Zhang |
Chemical encoding technology for combinatorial synthesis
|
US7329658B2
(en)
|
2003-02-06 |
2008-02-12 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
MXPA05009771A
(es)
|
2003-03-14 |
2005-10-26 |
Ono Pharmaceutical Co |
Derivados heterociclicos que contienen nitrogeno y medicamentos que los contienen como el ingrediente activo.
|
US7135469B2
(en)
|
2003-03-18 |
2006-11-14 |
Bristol Myers Squibb, Co. |
Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
|
GB0306430D0
(en)
|
2003-03-20 |
2003-04-23 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalysts
|
ES2423800T3
(es)
|
2003-03-28 |
2013-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos orgánicos para la inmunopotenciación
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
JP2004315613A
(ja)
|
2003-04-14 |
2004-11-11 |
Fuji Photo Film Co Ltd |
セルロースアシレートフィルム、その製造方法、偏光板保護膜、液晶表示装置、及びハロゲン化銀写真感光材料
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
CN102584813B
(zh)
|
2003-05-14 |
2016-07-06 |
Ngc药物公司 |
化合物及其在调节淀粉样蛋白β中的用途
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
WO2005021568A2
(en)
|
2003-08-27 |
2005-03-10 |
Biota, Inc. |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
JPWO2005023771A1
(ja)
|
2003-09-05 |
2006-11-02 |
小野薬品工業株式会社 |
ケモカインレセプターアンタゴニストおよびその医薬用途
|
WO2005025515A2
(en)
|
2003-09-12 |
2005-03-24 |
California Institute Of Technology |
Proteasome pathway inhibitors and related methods
|
JP4231379B2
(ja)
|
2003-10-15 |
2009-02-25 |
富士フイルム株式会社 |
潤滑剤組成物
|
EP1679309A4
(en)
|
2003-10-24 |
2007-03-28 |
Ono Pharmaceutical Co |
ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
|
AU2004299174A1
(en)
|
2003-12-10 |
2005-06-30 |
Merck Patent Gmbh |
Diacylhydrazine derivatives
|
WO2005093476A1
(en)
|
2004-03-25 |
2005-10-06 |
Fuji Photo Film Co., Ltd. |
Transparent film and optical compensatory film, polarizing plate and liquid-crystal display device employing it
|
WO2005095544A1
(en)
|
2004-03-25 |
2005-10-13 |
Merck Patent Gmbh |
Liquid crystal compounds, liquid crystal medium and liquid crystal display
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
EP1593713A1
(en)
|
2004-05-04 |
2005-11-09 |
Rolic AG |
Polymerizable dichromophoric dichroic azo dyes
|
GB0410604D0
(en)
|
2004-05-12 |
2004-06-16 |
Bp Chem Int Ltd |
Ethylene copolymers
|
PT1765360E
(pt)
*
|
2004-06-14 |
2009-12-24 |
Anacor Pharmaceuticals Inc |
Utilizações antivirais de complexos de ácido borínico
|
WO2006001463A1
(ja)
|
2004-06-23 |
2006-01-05 |
Ono Pharmaceutical Co., Ltd. |
S1p受容体結合能を有する化合物およびその用途
|
WO2006006490A1
(ja)
|
2004-07-08 |
2006-01-19 |
Ono Pharmaceutical Co., Ltd. |
スピロ化合物
|
GB0415879D0
(en)
|
2004-07-15 |
2004-08-18 |
Bp Chem Int Ltd |
Polymerisation catalyst
|
GB0418022D0
(en)
|
2004-08-12 |
2004-09-15 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalyst
|
GB0420396D0
(en)
|
2004-09-14 |
2004-10-13 |
Bp Chem Int Ltd |
Polyolefins
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
GB0424422D0
(en)
|
2004-11-04 |
2004-12-08 |
Bp Chem Int Ltd |
Polymerisation catalysts
|
JP4429149B2
(ja)
|
2004-11-26 |
2010-03-10 |
キヤノン株式会社 |
フルオレン化合物及び有機発光素子
|
WO2006061094A1
(en)
|
2004-12-11 |
2006-06-15 |
Merck Patent Gmbh |
Liquid crystal compounds, liquid crystal medium and liquid crystal display
|
EP1828217A2
(en)
|
2004-12-16 |
2007-09-05 |
Febit Biotech GmbH |
Polymerase-independent analysis of the sequence of polynucleotides
|
EP1831235B1
(en)
|
2004-12-16 |
2013-02-20 |
The Regents of The University of California |
Lung-targeted drugs
|
JP4749000B2
(ja)
|
2005-02-22 |
2011-08-17 |
富士フイルム株式会社 |
グリース組成物
|
US7622240B2
(en)
|
2005-02-28 |
2009-11-24 |
International Business Machines Corporation |
Low blur molecular resist
|
AU2006222563A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
EP1867704B1
(en)
|
2005-03-15 |
2010-09-15 |
FUJIFILM Corporation |
Surface treatment method using disc-like compound, (lubricating) composition for surface treatment, and surface-treated article
|
US20060229265A1
(en)
|
2005-03-30 |
2006-10-12 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
US20090156545A1
(en)
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
WO2006110656A2
(en)
|
2005-04-08 |
2006-10-19 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
WO2006119800A1
(en)
|
2005-05-09 |
2006-11-16 |
Technische Universität Braunschweig |
Light emitting compound for electroluminescent applications
|
US7576205B2
(en)
|
2005-06-13 |
2009-08-18 |
Agency For Science, Technology & Research |
Detectable threading intercalator
|
WO2007007588A1
(ja)
|
2005-07-08 |
2007-01-18 |
Ono Pharmaceutical Co., Ltd. |
平面性を有する環状基を母核とする化合物
|
WO2007011759A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
DE102005043165A1
(de)
|
2005-09-12 |
2007-03-22 |
Merck Patent Gmbh |
Metallkomplexe
|
EP1945222B1
(en)
|
2005-11-02 |
2012-12-26 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo[2,1-f] [1,2,4]-triazin-4-ylamines as igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
|
EP1942732A2
(en)
|
2005-11-02 |
2008-07-16 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
US7910595B2
(en)
|
2005-12-21 |
2011-03-22 |
Abbott Laboratories |
Anti-viral compounds
|
US20070208053A1
(en)
|
2006-01-19 |
2007-09-06 |
Arnold Lee D |
Fused heterobicyclic kinase inhibitors
|
DE602007008837D1
(de)
|
2006-02-14 |
2010-10-14 |
Vertex Pharma |
Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
|
AR060095A1
(es)
|
2006-03-29 |
2008-05-21 |
Schering Corp |
Derivados de himbacina monociclicos y biciclicos utiles como antogonistas de los receptores de trombina
|
WO2007125320A1
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
US7749983B2
(en)
|
2006-05-03 |
2010-07-06 |
Chimerix, Inc. |
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
|
EP2035395A2
(en)
|
2006-06-27 |
2009-03-18 |
Glenmark Pharmaceuticals S.A. |
Novel processes for the preparation of dpp iv inhibitors
|
JP2008007634A
(ja)
|
2006-06-29 |
2008-01-17 |
Fujifilm Corp |
潤滑剤組成物
|
EP2044061A2
(en)
|
2006-07-20 |
2009-04-08 |
Mehmet Kahraman |
Benzothiophene inhibitors of rho kinase
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
CA2659465A1
(en)
|
2006-08-22 |
2008-02-28 |
Redpoint Bio Corporation |
Heterocyclic compounds as sweetener enhancers
|
US7951789B2
(en)
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
NZ578556A
(en)
|
2007-01-12 |
2012-04-27 |
Biocryst Pharm Inc |
Antiviral nucleoside analogs
|
US20090016990A1
(en)
|
2007-01-24 |
2009-01-15 |
Alberte Randall S |
Antimicrobial Compositions
|
AU2008210411A1
(en)
|
2007-01-31 |
2008-08-07 |
Alios Biopharma, Inc. |
2-5A derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
|
JP2010520293A
(ja)
|
2007-03-07 |
2010-06-10 |
アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド |
複素環式部分を含有するメタロプロテアーゼ阻害剤
|
US8088566B2
(en)
|
2007-03-26 |
2012-01-03 |
Fujifilm Corporation |
Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
US7956020B2
(en)
|
2007-03-29 |
2011-06-07 |
Fujifilm Corporation |
Lubricant composition, mechanical element, and method for producing triazine derivatives
|
US8088940B2
(en)
|
2007-03-30 |
2012-01-03 |
Momentive Performance Materials Inc. |
Hydrolyzable silanes of low VOC-generating potential and resinous compositions containing same
|
US20120010170A1
(en)
|
2007-04-27 |
2012-01-12 |
Painter George R |
"Methods of Reducing Nephrotoxicity in Subjects Administered Nucleoside Phosphonates"
|
ES2393038T3
(es)
|
2007-05-10 |
2012-12-18 |
Biocryst Pharmaceuticals, Inc. |
Compuestos de tretrahidrofuro[3,4-D]dioxolano para su utlilización en el tratamiento de las infecciones víricas y del cáncer
|
US20110319459A1
(en)
|
2007-06-14 |
2011-12-29 |
Osta Biotechnologies |
Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
|
CA2727528A1
(en)
|
2007-06-14 |
2008-12-18 |
Osta Biotechnologies |
Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
CN100532388C
(zh)
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
KR101526024B1
(ko)
|
2007-07-19 |
2015-06-04 |
코니카 미놀타 어드밴스드 레이어즈 인코포레이티드 |
셀룰로오스 에스테르 필름, 셀룰로오스 에스테르 필름의 제조 방법, 그것을 사용한 편광판 및 액정 표시 장치
|
JP5604872B2
(ja)
|
2007-07-19 |
2014-10-15 |
コニカミノルタ株式会社 |
セルロースエステルフィルム
|
US9340506B2
(en)
|
2007-10-08 |
2016-05-17 |
Advinus Therapeutics Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
AR069740A1
(es)
|
2007-11-29 |
2010-02-17 |
Metabasis Therapeutics Inc |
Compuestos nucleosidos antivirales
|
JP5637859B2
(ja)
|
2007-12-13 |
2014-12-10 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
嚢胞性線維症膜コンダクタンスレギュレーターのモジュレーター
|
US20090181921A1
(en)
|
2007-12-21 |
2009-07-16 |
Alios Biopharma Inc. |
2-5a analogs and their methods of use
|
WO2009086192A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents
|
TW200942243A
(en)
|
2008-03-05 |
2009-10-16 |
Biocryst Pharm Inc |
Antiviral therapeutic agents
|
EP2098226A1
(de)
|
2008-03-06 |
2009-09-09 |
Forschungsverbund Berlin e.V. |
AKAP-PKA-Interaktionshemmer zur Anwendung in der Behandlung von Herzkrankheiten
|
ES2398684T3
(es)
|
2008-04-23 |
2013-03-21 |
Gilead Sciences, Inc. |
Análogos de carbanucleósido para el tratamiento antiviral
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
JP5712125B2
(ja)
|
2008-05-27 |
2015-05-07 |
トリリンク バイオテクノロジーズ |
高温で開始される核酸増幅のための、化学修飾されたヌクレオシド5’−三リン酸
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US7910020B2
(en)
|
2008-06-27 |
2011-03-22 |
Transitions Optical, Inc. |
Liquid crystal compositions comprising mesogen containing compounds
|
US7910019B2
(en)
|
2008-06-27 |
2011-03-22 |
Transitions Optical, Inc. |
Mesogen containing compounds
|
US8628685B2
(en)
|
2008-06-27 |
2014-01-14 |
Transitions Optical, Inc |
Mesogen-containing compounds
|
US7803285B2
(en)
|
2008-07-01 |
2010-09-28 |
Gentex Corporation |
Liquid crystal display device and associated liquid crystal media for use in the same
|
WO2010002877A2
(en)
|
2008-07-03 |
2010-01-07 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
GB0812297D0
(en)
|
2008-07-04 |
2008-08-13 |
Lucite Int Uk Ltd |
Novel carbonylation ligand sand thier use of in the carbonylation of ethylenically unsaturated compounds
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
JP5295692B2
(ja)
|
2008-09-10 |
2013-09-18 |
豊和工業株式会社 |
自動開閉防音サッシ
|
CA2737661C
(en)
|
2008-09-23 |
2019-08-20 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
US20100096603A1
(en)
|
2008-10-20 |
2010-04-22 |
Nitto Denko Corporation |
Optical devices responsive to near infrared laser and methods of modulating light
|
AR074231A1
(es)
|
2008-11-27 |
2010-12-29 |
Boehringer Ingelheim Int |
Derivados de 6, 7, 8, 9-tetrahidro-5h-1, 4, 7, 10a-tetraaza-ciclohept[f]indeno, composiciones farmacéuticas que contienen estos compuestos, su uso en el agonismo del receptor 5-ht2c y procesos para prepararlos.
|
WO2010073126A2
(en)
|
2008-12-22 |
2010-07-01 |
The Governors Of The University Of Alberta |
Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
US9040718B2
(en)
|
2009-01-22 |
2015-05-26 |
The University Of Rochester |
Hybrid host materials for electrophosphorescent devices
|
KR20100087540A
(ko)
|
2009-01-28 |
2010-08-05 |
삼성전자주식회사 |
잉크젯 기록용 잉크 조성물
|
EA201190178A1
(ru)
|
2009-03-20 |
2012-06-29 |
Алиос Биофарма, Инк. |
Замещённые нуклеозидные и нуклеотидные аналоги
|
WO2010108135A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
US20110212994A1
(en)
|
2009-06-26 |
2011-09-01 |
Brian Clem |
Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
WO2011016430A1
(ja)
|
2009-08-04 |
2011-02-10 |
三菱化学株式会社 |
光電変換素子及びこれを用いた太陽電池
|
AU2010281265A1
(en)
|
2009-08-05 |
2012-03-22 |
Versitech Limited |
Antiviral compounds and methods of making and using thereof
|
NZ598808A
(en)
|
2009-09-09 |
2014-07-25 |
Celgene Avilomics Res Inc |
Pi3 kinase inhibitors and uses thereof
|
CA2773561A1
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
MX2012003126A
(es)
|
2009-09-21 |
2012-06-19 |
Gilead Sciences Inc |
Procesos e intermedios para la preparacion de analogos de 1'-carbonucleosidos sustituidos.
|
EP2480552B1
(en)
|
2009-09-21 |
2016-11-09 |
Gilead Sciences, Inc. |
2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US20120264810A1
(en)
|
2009-09-22 |
2012-10-18 |
The University Of British Columbia |
Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
|
WO2011038207A1
(en)
|
2009-09-25 |
2011-03-31 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing thyroid hormone receptor agonists and methods of use
|
DE102010035730A1
(de)
|
2009-09-28 |
2011-04-07 |
Merck Patent Gmbh |
Polymerisierbare Verbindungen und ihre Verwendung in Flüssigkristallanzeigen
|
WO2011057214A2
(en)
|
2009-11-09 |
2011-05-12 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
CN102000103B
(zh)
|
2009-12-21 |
2011-12-21 |
郑州大学 |
2’-氟-4’-叠氮-核苷类似物或其盐的药物应用
|
TWI485153B
(zh)
|
2010-01-13 |
2015-05-21 |
Sanofi Aventis |
2,5,7-經取代唑并嘧啶衍生物
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
JP5816635B2
(ja)
|
2010-03-05 |
2015-11-18 |
カリオファーム セラピューティクス,インコーポレイテッド |
核輸送調節剤およびその使用
|
EP2550260A1
(en)
|
2010-03-24 |
2013-01-30 |
Medical University Of South Carolina |
Compositions and methods for the treatment of degenerative diseases
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
FR2960235B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede d'oligomerisation des olefines utilisant une composition comprenant un complexe organometallique contenant un ligand alcoxy fonctionnalise par un hetero-atome.
|
FR2960234B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede de dimerisation de l'ethylene en butene-1 utilisant une composition comprenant un complexe a base de titane et un ligand alcoxy fonctionnalise par un hetero-atome.
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
US8614021B2
(en)
|
2010-06-10 |
2013-12-24 |
The United States Of America As Represented By The Secretary Of The Army |
Agents for enhanced charge transport across microbial membranes
|
BR112013001267A2
(pt)
|
2010-07-19 |
2016-05-17 |
Gilead Sciences Inc |
métodos para a preparação de pró-fármacos de fosforamidato diasteromericamente puro
|
US20120027752A1
(en)
|
2010-07-22 |
2012-02-02 |
Gilead Sciences, Inc. |
Methods and compounds for treating paramyxoviridae virus infections
|
CN102351931B
(zh)
|
2010-09-07 |
2014-01-22 |
河南省科学院高新技术研究中心 |
嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
DE102010045369A1
(de)
|
2010-09-14 |
2012-03-15 |
Merck Patent Gmbh |
Materialien für organische Elektrolumineszenzvorrichtungen
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
CN103209987B
(zh)
|
2010-09-22 |
2017-06-06 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
ES2701020T3
(es)
|
2010-09-22 |
2019-02-20 |
Alios Biopharma Inc |
Nucleósidos azido y análogos nucleotídicos
|
WO2012068340A2
(en)
|
2010-11-18 |
2012-05-24 |
Opko Curna Llc |
Antagonat compositions and methods of use
|
WO2012083048A2
(en)
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
AU2011349844B2
(en)
|
2010-12-20 |
2017-06-01 |
Gilead Sciences, Inc. |
Combinations for treating HCV
|
EP2655334B1
(en)
|
2010-12-22 |
2018-10-03 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
CA2819041A1
(en)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
TWI450891B
(zh)
|
2010-12-29 |
2014-09-01 |
Dev Center Biotechnology |
新穎微管蛋白抑制劑
|
US20120219568A1
(en)
|
2011-02-24 |
2012-08-30 |
Zhejiang University |
Epidithiodioxopiprazines and uses thereof in treating cancer
|
AU2012223528A1
(en)
|
2011-03-02 |
2013-10-24 |
Joseph M. Fayad |
Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection
|
WO2012121973A1
(en)
|
2011-03-04 |
2012-09-13 |
Life Technologies Corporation |
Compounds and methods for conjugation of biomolecules
|
BR112013023681A2
(pt)
|
2011-03-16 |
2016-12-13 |
Hoffmann La Roche |
compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos
|
JP2012216832A
(ja)
|
2011-03-30 |
2012-11-08 |
Mitsubishi Chemicals Corp |
光電変換素子、太陽電池、太陽電池モジュール及びインク
|
JP2014510155A
(ja)
|
2011-04-06 |
2014-04-24 |
ザ トラスティーズ オブ プリンストン ユニバーシティ |
抗ウイルス組み合わせ治療薬
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
BR112013026219A2
(pt)
|
2011-04-13 |
2016-07-26 |
Gilead Sciences Inc |
análogos de n-nucleosídeo 1'-substituída pirimidina para tratamento antiviral
|
KR20130138840A
(ko)
|
2011-04-13 |
2013-12-19 |
머크 샤프 앤드 돔 코포레이션 |
2''-치환된 뉴클레오시드 유도체 및 바이러스성 질환의 치료를 위한 그의 사용 방법
|
GB201108825D0
(en)
|
2011-05-25 |
2011-07-06 |
Univ Dundee |
Morpholino compounds, uses and methods
|
US20130018011A1
(en)
|
2011-06-10 |
2013-01-17 |
Hassan Javanbakht |
Method of treating dengue fever
|
WO2013000855A1
(en)
|
2011-06-30 |
2013-01-03 |
Santaris Pharma A/S |
Hcv combination therapy
|
FR2977586B1
(fr)
|
2011-07-08 |
2013-07-12 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
CN104039784B
(zh)
|
2011-09-02 |
2017-08-22 |
拜耳知识产权有限责任公司 |
取代的增环嘧啶及其用途
|
CN102286047A
(zh)
|
2011-09-14 |
2011-12-21 |
郑州大学 |
2’-脱氧-2’-氟-4’-三氮唑取代-β-D胞苷类似物、其制备方法及其应用
|
UA116087C2
(uk)
|
2011-09-16 |
2018-02-12 |
Гіліад Фармассет Елелсі |
Композиція для лікування вірусу гепатиту c
|
JP2014530195A
(ja)
|
2011-09-16 |
2014-11-17 |
アッヴィ・インコーポレイテッド |
Hcvを治療するための方法
|
WO2013044030A1
(en)
|
2011-09-23 |
2013-03-28 |
Enanta Pharmaceuticals, Inc. |
2'-chloroacetylenyl substituted nucleoside derivatives
|
WO2013056132A2
(en)
|
2011-10-14 |
2013-04-18 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
|
FR2982858B1
(fr)
|
2011-11-18 |
2013-11-29 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
WO2013090420A2
(en)
|
2011-12-12 |
2013-06-20 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid antiviral conjugates and their uses
|
FR2984322B1
(fr)
|
2011-12-16 |
2013-12-20 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
AU2012358804B2
(en)
|
2011-12-22 |
2018-04-19 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
SG11201402826YA
(en)
|
2011-12-22 |
2014-12-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013101552A1
(en)
|
2011-12-28 |
2013-07-04 |
Abbvie Inc. |
Methods for treating hcv
|
CN102603836A
(zh)
|
2012-02-10 |
2012-07-25 |
郑州大学 |
五味子丙素简化物、类似物及其制备方法和应用
|
JP6242378B2
(ja)
|
2012-03-13 |
2017-12-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス処置のための2’−置換カルバヌクレオシド類似体
|
TWI635111B
(zh)
|
2012-03-16 |
2018-09-11 |
馬克專利公司 |
共軛聚合物
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
WO2013142124A1
(en)
|
2012-03-21 |
2013-09-26 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
PL2827875T3
(pl)
|
2012-03-21 |
2019-07-31 |
Janssen Biopharma, Inc. |
Podstawione nukleozydy, nukleotydy i ich analogi
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9012427B2
(en)
|
2012-03-22 |
2015-04-21 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
CN104204009B
(zh)
|
2012-03-29 |
2016-08-17 |
英派尔科技开发有限公司 |
二氧杂硼烷共聚物及其应用
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
JP2013237721A
(ja)
|
2012-05-11 |
2013-11-28 |
Nitto Denko Corp |
再剥離用水分散型アクリル系粘着剤組成物、及び粘着シート
|
JP2015529689A
(ja)
|
2012-06-04 |
2015-10-08 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
有機半導体
|
US9682970B2
(en)
|
2012-06-29 |
2017-06-20 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
CN104583224A
(zh)
|
2012-07-03 |
2015-04-29 |
百时美施贵宝公司 |
制备用于治疗病毒感染的核苷化合物的富含非对映体的氨基磷酸酯衍生物的方法
|
US9682958B2
(en)
|
2012-07-23 |
2017-06-20 |
Merck Patent Gmbh |
Ligands and their preparation
|
US20140038991A1
(en)
|
2012-08-06 |
2014-02-06 |
Astar Biotech Llc |
Protein Kinase Inhibitors
|
US20150284422A1
(en)
|
2012-08-10 |
2015-10-08 |
Epizyme, Inc. |
Inhibitors of protein methyltransferase dot1l and methods of use thereof
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
WO2014035140A2
(en)
|
2012-08-30 |
2014-03-06 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating histone methyltransferase activity
|
EP2712868A1
(en)
|
2012-09-28 |
2014-04-02 |
B. Braun Melsungen AG |
5-Fluoruoracil Derivatives
|
US10513534B2
(en)
|
2012-10-08 |
2019-12-24 |
Idenix Pharmaceuticals Llc |
2′-chloro nucleoside analogs for HCV infection
|
DE102012109685A1
(de)
|
2012-10-11 |
2014-04-17 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Verfahren zur Umwandlung reaktiver Gruppen an Si-C-gebundenen Resten von Silanen unter gleichzeitiger Vergrößerung von deren räumlichem Abstand zueinander
|
US9242988B2
(en)
*
|
2012-10-17 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
US9457039B2
(en)
|
2012-10-17 |
2016-10-04 |
Merck Sharp & Dohme Corp. |
2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
KR20120135501A
(ko)
|
2012-10-29 |
2012-12-14 |
에스에프씨 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
JP6463273B2
(ja)
|
2012-12-14 |
2019-01-30 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
複屈折rmレンズ
|
SG11201504554UA
(en)
|
2012-12-21 |
2015-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2014100498A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
FR2999917B1
(fr)
|
2012-12-26 |
2017-06-23 |
Oreal |
Polymere a empreinte moleculaire pour pieger selectivement les molecules odorantes
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
JP6024479B2
(ja)
|
2013-01-28 |
2016-11-16 |
コニカミノルタ株式会社 |
光学フィルム、円偏光板および画像表示装置
|
WO2014124458A1
(en)
|
2013-02-11 |
2014-08-14 |
The Regents Of The University Of California |
Compositions and methods for treating neurodegenerative diseases
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
US20140309413A1
(en)
|
2013-03-11 |
2014-10-16 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
US9790291B2
(en)
|
2013-03-14 |
2017-10-17 |
Formosa Plastics Corporation, Usa |
Non-phthalate compounds as electron donors for polyolefin catalysts
|
JP6329764B2
(ja)
|
2013-03-15 |
2018-05-23 |
信越化学工業株式会社 |
対称ハイパーブランチ型シリコーン変性重合性化合物、及びそのモジュール化した製造方法
|
JP2016518316A
(ja)
|
2013-03-15 |
2016-06-23 |
セルジーン アビロミクス リサーチ, インコーポレイテッド |
Mk2阻害剤およびそれらの使用
|
TW201542578A
(zh)
|
2013-06-26 |
2015-11-16 |
Alios Biopharma Inc |
經取代之核苷、核苷酸及其類似物
|
WO2015003146A1
(en)
|
2013-07-03 |
2015-01-08 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
WO2015006280A1
(en)
|
2013-07-10 |
2015-01-15 |
Vertex Pharmaceuticals Incorporated |
Fused piperidine amides as modulators of ion channels
|
CN104086612A
(zh)
|
2013-07-17 |
2014-10-08 |
郑州大学 |
4-取代胺基-2′-脱氧-2′-氟-4′-叠氮-β-D-胞苷类核苷化合物、制备方法及其应用
|
WO2015016187A1
(ja)
|
2013-07-29 |
2015-02-05 |
富士フイルム株式会社 |
非水二次電池用電解液および非水二次電池
|
US11383266B2
(en)
|
2013-08-19 |
2022-07-12 |
Queen's University At Kingston |
Carbene-functionalized composite materials
|
CA2922703A1
(en)
|
2013-08-29 |
2015-03-05 |
Baylor College Of Medicine |
Compositions and methods for the treatment of metabolic and body weight related disorders
|
HRP20220911T1
(hr)
|
2013-09-11 |
2022-10-28 |
Emory University |
Sastav nukleotida i nukleozida i njihova uporaba
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
WO2015051169A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
SG10201804835VA
(en)
|
2013-10-11 |
2018-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
MX2016005393A
(es)
|
2013-10-25 |
2016-08-11 |
Abbvie Inc |
Metodos para tratar vhc.
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
US20150167017A1
(en)
|
2013-12-13 |
2015-06-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
CN103709220B
(zh)
|
2014-01-13 |
2016-02-17 |
河南省科学院高新技术研究中心 |
3-甲基尿苷及4-甲基胞苷核苷类化合物、合成方法及其药物用途
|
EP2896678B1
(en)
|
2014-01-21 |
2018-10-17 |
Merck Patent GmbH |
Liquid crystal display
|
MA39317A1
(fr)
|
2014-02-06 |
2018-01-31 |
Riboscience Llc |
Dérivés de nucléosides à substitution 4'-difluorométhyle utilisés en tant qu'inhibiteurs de la réplication de l'arn du virus de la grippe
|
JP6144215B2
(ja)
|
2014-02-07 |
2017-06-07 |
富士フイルム株式会社 |
光電変換素子およびその使用方法、光センサ、並びに、撮像素子
|
WO2015129672A1
(ja)
|
2014-02-27 |
2015-09-03 |
Dic株式会社 |
液晶表示装置
|
EP3730590A1
(de)
|
2014-03-10 |
2020-10-28 |
Merck Patent GmbH |
Flüssigkristalline medien mit homöotroper ausrichtung
|
WO2015143712A1
(en)
|
2014-03-28 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors
|
US9399637B2
(en)
|
2014-03-28 |
2016-07-26 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
EP3131538B1
(en)
|
2014-04-15 |
2019-12-18 |
Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO |
New anti-clostridium compounds
|
EP3157572A4
(en)
|
2014-06-19 |
2018-02-14 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
EP3157573A4
(en)
|
2014-06-19 |
2018-02-21 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
US20170136132A1
(en)
|
2014-06-19 |
2017-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2015198915A1
(ja)
|
2014-06-23 |
2015-12-30 |
Dic株式会社 |
重合性液晶組成物及び該組成物を用いて作製した光学異方体、位相差膜、位相差パターニング膜
|
TN2016000566A1
(en)
|
2014-06-24 |
2018-04-04 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2015200219A1
(en)
|
2014-06-24 |
2015-12-30 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
CN107974256A
(zh)
|
2014-07-15 |
2018-05-01 |
Dic株式会社 |
液晶显示装置和聚合性液晶组合物
|
TWI678369B
(zh)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
用於治療呼吸道合胞病毒感染之噻吩並[3,2-d]嘧啶、呋喃並[3,2-d]嘧啶及吡咯並[3,2-d]嘧啶化合物類
|
KR102289820B1
(ko)
|
2014-08-01 |
2021-08-17 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
WO2016029186A1
(en)
|
2014-08-22 |
2016-02-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Metal-assisted delayed fluorescent materials as co-host materials for fluorescent oleds
|
EP2990461B1
(en)
|
2014-08-25 |
2018-09-19 |
Merck Patent GmbH |
Liquid crystal medium
|
JP6326140B2
(ja)
|
2014-08-27 |
2018-05-16 |
富士フイルム株式会社 |
化合物、組成物、膜、光学機器
|
WO2016041877A1
(en)
|
2014-09-15 |
2016-03-24 |
Medivir Ab |
Methods for the preparation of diastereomerically pure phosphoramidate prodrugs
|
EP3212201B1
(en)
|
2014-10-28 |
2022-10-19 |
BCI Pharma |
Nucleoside kinase inhibitors
|
TWI687432B
(zh)
|
2014-10-29 |
2020-03-11 |
美商基利科學股份有限公司 |
絲狀病毒科病毒感染之治療
|
US20170334941A1
(en)
|
2014-10-31 |
2017-11-23 |
Cocrystal Pharma, Inc. |
2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
US20170343847A1
(en)
|
2014-11-06 |
2017-11-30 |
Merck Patent Gmbh |
Light modulation element
|
US20170369780A1
(en)
|
2014-11-11 |
2017-12-28 |
Merck Patent Gmbh |
Bimesogenic compounds and mesogenic media
|
CN105646629A
(zh)
|
2014-11-25 |
2016-06-08 |
广州市恒诺康医药科技有限公司 |
L-核苷类化合物及其应用
|
CN105777580B
(zh)
|
2014-12-18 |
2018-05-18 |
湖南化工研究院有限公司 |
酰基乙腈类化合物及其制备方法与应用
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
EP3234689B1
(en)
|
2014-12-19 |
2020-01-29 |
Merck Patent GmbH |
Light modulation element
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
WO2016107664A1
(en)
|
2014-12-30 |
2016-07-07 |
Merck Patent Gmbh |
Bimesogenic compounds and mesogenic media
|
US20160237106A1
(en)
|
2015-01-14 |
2016-08-18 |
Riboscience Llc |
4'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replication
|
WO2016116508A1
(de)
|
2015-01-20 |
2016-07-28 |
Cynora Gmbh |
Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen
|
CN107109233A
(zh)
|
2015-01-20 |
2017-08-29 |
捷恩智株式会社 |
液晶组合物及液晶显示元件
|
EP3048159B1
(en)
|
2015-01-22 |
2019-08-07 |
Merck Patent GmbH |
Liquid crystal medium
|
WO2016116254A1
(en)
|
2015-01-23 |
2016-07-28 |
Merck Patent Gmbh |
Light modulation element
|
US20180004045A1
(en)
|
2015-01-23 |
2018-01-04 |
Merck Patent Gmbh |
Light modulation element
|
KR102539268B1
(ko)
|
2015-02-10 |
2023-06-07 |
메르크 파텐트 게엠베하 |
액정 매질
|
JP6485106B2
(ja)
|
2015-02-24 |
2019-03-20 |
Jnc株式会社 |
液晶組成物および液晶表示素子
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
KR20160110900A
(ko)
|
2015-03-13 |
2016-09-22 |
메르크 파텐트 게엠베하 |
액정 매질
|
KR102587314B1
(ko)
|
2015-03-13 |
2023-10-12 |
메르크 파텐트 게엠베하 |
액정 매질
|
JP6325171B2
(ja)
|
2015-03-17 |
2018-05-16 |
富士フイルム株式会社 |
有機半導体組成物、及び、有機半導体素子の製造方法
|
JP6870609B2
(ja)
|
2015-03-24 |
2021-05-12 |
Jnc株式会社 |
液晶組成物および液晶表示素子
|
US20180271873A1
(en)
|
2015-04-01 |
2018-09-27 |
The California Institute For Biomedical Research |
Methods for treating viral infections
|
FR3034767A1
(fr)
|
2015-04-07 |
2016-10-14 |
Centre Nat Rech Scient |
Reduction des fonctions carbonyles de glucides et derives de glucides en milieu aqueux par le dithionite de sodium
|
US10479940B2
(en)
|
2015-04-23 |
2019-11-19 |
Jnc Corporation |
Liquid crystal composition and liquid crystal display device
|
WO2016172631A2
(en)
|
2015-04-24 |
2016-10-27 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
CN106279322B
(zh)
|
2015-05-15 |
2019-07-30 |
上海唐润医药科技有限公司 |
抗丙肝病毒的核苷类化合物及其应用
|
DE102015210388A1
(de)
|
2015-06-05 |
2016-12-08 |
Siemens Aktiengesellschaft |
Organische Heterozyklische Alkalimetallsalze als n-Dotierstoffe in der Organischen Elektronik
|
ES2744775T3
(es)
|
2015-07-06 |
2020-02-26 |
Bayer Cropscience Ag |
Heterociclos que contienen nitrógeno como pesticidas
|
WO2017019817A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
WO2017019822A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Pellet composition containing repair cells
|
WO2017019830A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
WO2017023894A1
(en)
|
2015-08-03 |
2017-02-09 |
Raze Therapeutics, Inc. |
Mthfd2 inhibitors and uses thereof
|
CN108026136A
(zh)
|
2015-08-06 |
2018-05-11 |
奇默里克斯公司 |
作为有用的抗病毒剂的吡咯并嘧啶核苷及其类似物
|
US10738074B2
(en)
|
2015-08-13 |
2020-08-11 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as STING agonists
|
TWI730980B
(zh)
|
2015-08-26 |
2021-06-21 |
比利時商健生藥品公司 |
使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
|
KR20180051582A
(ko)
|
2015-09-09 |
2018-05-16 |
메르크 파텐트 게엠베하 |
액정 매질
|
CN106518766A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
新型二芳基脲类化合物,其制备方法及其医药用途
|
CN106518767A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
|
JP2018532869A
(ja)
|
2015-09-15 |
2018-11-08 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
ホメオトロピック配向を有する液晶媒体
|
BR112018005048B8
(pt)
|
2015-09-16 |
2021-03-23 |
Gilead Sciences Inc |
uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por coronaviridae
|
CN105218523B
(zh)
|
2015-09-18 |
2019-08-23 |
上海吉铠医药科技有限公司 |
吡啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
|
CN105254624B
(zh)
|
2015-09-18 |
2019-08-09 |
上海吉铠医药科技有限公司 |
异噻唑衍生物pim激酶抑制剂及其制备方法与在制药中的应用
|
CN105130959B
(zh)
|
2015-09-18 |
2018-08-03 |
上海吉铠医药科技有限公司 |
嘧啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
|
US10875842B2
(en)
|
2015-09-28 |
2020-12-29 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
WO2017066797A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Trinucleotide mrna cap analogs
|
EP3362460A1
(en)
|
2015-10-16 |
2018-08-22 |
Modernatx, Inc. |
Mrna cap analogs and methods of mrna capping
|
ES2914225T3
(es)
|
2015-10-16 |
2022-06-08 |
Modernatx Inc |
Análogos de cap de ARNm con enlace de fosfato modificado
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
WO2017068875A1
(ja)
|
2015-10-23 |
2017-04-27 |
Jnc株式会社 |
液晶組成物および液晶表示素子
|
CN107108498B
(zh)
|
2015-10-26 |
2020-08-21 |
株式会社Lg化学 |
胺化合物和包含其的有机发光元件
|
WO2017073933A1
(ko)
|
2015-10-26 |
2017-05-04 |
주식회사 엘지화학 |
스피로형 화합물 및 이를 포함하는 유기 발광 소자
|
WO2017073931A1
(ko)
|
2015-10-28 |
2017-05-04 |
주식회사 엘지화학 |
스피로형 화합물 및 이를 포함하는 유기 발광 소자
|
US11191774B2
(en)
|
2015-11-25 |
2021-12-07 |
The Regents Of The University Of California |
Drug formulations for cancer treatment
|
EP3383874A1
(de)
|
2015-12-03 |
2018-10-10 |
Bayer CropScience Aktiengesellschaft |
Mesolonische halogenierte 3-(acetyl)-1-[(1,3-thiazol-5-yl)methyl]-1h-imidazo[1,2-a]pyridin-4-ium-2-olat derivate und verwandte verbindungen als insektizide
|
CN108368424B
(zh)
|
2015-12-11 |
2022-06-03 |
默克专利股份有限公司 |
可聚合化合物及其在液晶显示器中的用途
|
CN106892920B
(zh)
|
2015-12-18 |
2019-12-13 |
中国医学科学院医药生物技术研究所 |
苦豆碱衍生物、其制备方法及用途
|
KR102419178B1
(ko)
|
2015-12-29 |
2022-07-11 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
TWI740910B
(zh)
|
2016-03-09 |
2021-10-01 |
美商艾洛斯生物製藥公司 |
非環抗病毒劑
|
WO2017153186A1
(en)
|
2016-03-10 |
2017-09-14 |
Janssen Pharmaceutica Nv |
Substituted nucleoside analogues for use as prmt5 inhibitors
|
MX2018011105A
(es)
|
2016-03-16 |
2018-11-22 |
Kura Oncology Inc |
Inhibidores sustituidos de menina-mll y metodos de uso.
|
WO2017165489A1
(en)
|
2016-03-23 |
2017-09-28 |
Emory University |
Antiviral agents for treating zika and dengue virus infections
|
CN107286190A
(zh)
|
2016-04-13 |
2017-10-24 |
刘沛 |
核苷之烃氧基苄基氨基磷酸/膦酸酯衍生物的制备及其医药用途
|
WO2017184668A1
(en)
|
2016-04-20 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating flaviviridae virus infections
|
CA3026196A1
(en)
|
2016-06-01 |
2017-12-07 |
Queen's University At Kingston |
Etching metal using n-heterocyclic carbenes
|
GB201609600D0
(en)
|
2016-06-01 |
2016-07-13 |
Nucuna Biomed Ltd |
Cancer treatments
|
WO2018015323A2
(en)
|
2016-07-20 |
2018-01-25 |
Merck Patent Gmbh |
Switching layer for use in an optical switching element
|
CN109890831A
(zh)
|
2016-08-12 |
2019-06-14 |
詹森生物制药有限公司 |
被取代的核苷、核苷酸以及它们的类似物
|
JP2018044028A
(ja)
|
2016-09-12 |
2018-03-22 |
オルガノサイエンス株式会社 |
液晶組成物
|
WO2018067615A1
(en)
|
2016-10-03 |
2018-04-12 |
Sigilon Therapeutics, Inc. |
Compounds, devices, and uses thereof
|
WO2018065356A1
(en)
|
2016-10-05 |
2018-04-12 |
Merck Patent Gmbh |
Organic semiconducting compounds
|
WO2018098206A1
(en)
|
2016-11-23 |
2018-05-31 |
Cv6 Therapeutics (Ni) Limited |
Hydantoin containing deoxyuridine triphosphatase inhibitors
|
WO2018106820A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
JP6551618B2
(ja)
|
2016-12-16 |
2019-07-31 |
Dic株式会社 |
表示素子用封止材料組成物、及び、それを用いた表示素子
|
JP6547912B2
(ja)
|
2016-12-19 |
2019-07-24 |
Dic株式会社 |
重合性組成物、及び、それを用いた光学異方体
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
EP3573718B1
(en)
|
2017-01-27 |
2022-06-01 |
Janssen Biotech, Inc. |
Cyclic dinucleotides as sting agonists
|
US12089486B2
(en)
|
2017-02-08 |
2024-09-10 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
EP4331677A3
(en)
|
2017-03-14 |
2024-05-29 |
Gilead Sciences, Inc. |
Methods of treating feline coronavirus infections
|
US11944627B2
(en)
|
2017-03-24 |
2024-04-02 |
Kura Oncology, Inc. |
Methods for treating hematological malignancies and Ewing's sarcoma
|
WO2018183635A1
(en)
|
2017-03-31 |
2018-10-04 |
Peloton Therapeutics, Inc. |
Cd73 inhibitors and uses thereof
|
ES2919474T3
(es)
|
2017-04-07 |
2022-07-26 |
Medshine Discovery Inc |
Derivado de [1,2,4]triazolo[1,5-c]pirimidina como inhibidor del receptor A2A
|
EP3609977B1
(de)
|
2017-04-13 |
2024-05-29 |
Merck Patent GmbH |
Zusammensetzung für organische elektronische vorrichtungen
|
US10836787B2
(en)
|
2017-05-01 |
2020-11-17 |
Gilead Sciences, Inc. |
Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
|
WO2018208667A1
(en)
|
2017-05-12 |
2018-11-15 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
WO2018213185A1
(en)
|
2017-05-17 |
2018-11-22 |
Drexel University |
Rela inhibitors for biofilm disruption
|
AU2018272065B2
(en)
|
2017-05-25 |
2020-08-13 |
Hyconix, Inc. |
Direct oxidation of olefins to oxygenated species
|
US10004719B1
(en)
|
2017-05-30 |
2018-06-26 |
Taigen Biotechnology Co., Ltd. |
Solid dispersion formulation
|
WO2018222172A1
(en)
|
2017-05-30 |
2018-12-06 |
Taigen Biotechnology Co., Ltd. |
Solid dispersion formulation
|
AU2018276305A1
(en)
|
2017-05-31 |
2019-12-19 |
Commonwealth Scientific And Industrial Research Organisation |
Inhibiting hydrocarbon hydrate agglomeration
|
US11542248B2
(en)
|
2017-06-08 |
2023-01-03 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
JP2018203945A
(ja)
|
2017-06-08 |
2018-12-27 |
Dic株式会社 |
重合性液晶組成物、及び、それを用いた光学異方体
|
EP3642182A4
(en)
|
2017-06-21 |
2020-12-09 |
Wave Life Sciences Ltd. |
COMPOUNDS, COMPOSITIONS AND SYNTHESIS METHODS
|
WO2019014247A1
(en)
|
2017-07-11 |
2019-01-17 |
Gilead Sciences, Inc. |
COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS
|
US11548893B2
(en)
|
2017-07-15 |
2023-01-10 |
Arisan Therapeutics Inc. |
Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
|
DK3678668T3
(da)
|
2017-09-08 |
2024-04-08 |
Univ Leland Stanford Junior |
ENPP1-inhibitorer og deres anvendelse til behandling af kræft
|
CN111094298A
(zh)
|
2017-09-13 |
2020-05-01 |
默克专利股份有限公司 |
有机半导体化合物
|
AU2018332540B2
(en)
|
2017-09-18 |
2023-10-05 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
KR20190041918A
(ko)
|
2017-10-13 |
2019-04-23 |
메르크 파텐트 게엠베하 |
액정 매질
|
EP3700527A4
(en)
|
2017-10-25 |
2021-03-10 |
Children's Medical Center Corporation |
PAPD5 INHIBITORS AND THEIR METHODS OF USE
|
WO2019086400A1
(en)
|
2017-11-02 |
2019-05-09 |
Merck Patent Gmbh |
Organic semiconducting compounds
|
CN109748944B
(zh)
|
2017-11-03 |
2021-12-10 |
中国科学院上海药物研究所 |
5’-脱氧-5’-异丙基取代氨基核苷类化合物、其制备方法和用途
|
CN109748943A
(zh)
|
2017-11-03 |
2019-05-14 |
中国科学院上海药物研究所 |
2’-c-甲基取代核苷类化合物及其制备与用途
|
CN109748921B
(zh)
|
2017-11-03 |
2022-03-22 |
中国科学院上海药物研究所 |
N-叔丁氧羰基保护的杂环类化合物、其制备方法及其用于制备c-核苷类似物的方法
|
WO2019092171A1
(en)
|
2017-11-09 |
2019-05-16 |
Inflazome Limited |
Novel sulfonamide carboxamide compounds
|
JP7207321B2
(ja)
|
2017-11-16 |
2023-01-18 |
Jsr株式会社 |
レジスト下層膜形成用組成物、レジスト下層膜及びその形成方法、パターニングされた基板の製造方法並びに化合物
|
US11685761B2
(en)
|
2017-12-20 |
2023-06-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
EP3502210B1
(en)
|
2017-12-20 |
2020-09-09 |
Merck Patent GmbH |
Liquid-crystal medium
|
EP3502209B1
(en)
|
2017-12-20 |
2020-10-14 |
Merck Patent GmbH |
Liquid-crystalline media having homeotropic alignment
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
CA3087192A1
(en)
|
2017-12-27 |
2019-07-04 |
Raymond F. Schinazi |
Combined modalities for nucleosides and/or nadph oxidase (nox) inhibitors as myeloid-specific antiviral agents
|
CN111094317B
(zh)
|
2017-12-29 |
2023-03-31 |
上海和誉生物医药科技有限公司 |
一种具有cd73抑制活性的膦酸衍生物、其制备方法和应用
|
JP2019137753A
(ja)
|
2018-02-08 |
2019-08-22 |
シャープ株式会社 |
液晶組成物および液晶ディスプレイ
|
EP3749649A1
(en)
|
2018-02-08 |
2020-12-16 |
ENYO Pharma |
Non-fused thiophene derivatives and their uses
|
JP7417530B2
(ja)
|
2018-03-09 |
2024-01-18 |
アーカス バイオサイエンシズ インコーポレイティド |
優先投与される免疫増強薬
|
CN108276352B
(zh)
|
2018-03-13 |
2022-09-20 |
华东理工大学 |
一种具有杀线虫活性的含氮杂环化合物及其制法和用途
|
WO2019195056A1
(en)
|
2018-04-04 |
2019-10-10 |
Sigilon Therapeutics, Inc. |
Methods, compositions, and implantable elements comprising stem cells
|
WO2019215076A1
(de)
|
2018-05-08 |
2019-11-14 |
Bayer Aktiengesellschaft |
Verfahren zur herstellung stickstoffhaltiger heterocyclen
|
CN108727344A
(zh)
|
2018-05-14 |
2018-11-02 |
嘉兴特科罗生物科技有限公司 |
一种化合物及其合成方法和应用
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
WO2020032152A1
(ja)
|
2018-08-09 |
2020-02-13 |
ヤマサ醤油株式会社 |
4'-置換ヌクレオシド誘導体の立体選択的合成法
|
CN110215456A
(zh)
|
2019-06-25 |
2019-09-10 |
华中农业大学 |
一种由gc376与gs-441524组成的猫冠状病毒抑制剂组合物
|
CN110330540A
(zh)
|
2019-08-08 |
2019-10-15 |
木天(济南)生物科技有限公司 |
核苷盐及其制备方法
|
CN110724174B
(zh)
|
2019-09-10 |
2021-02-05 |
广州六顺生物科技股份有限公司 |
吡咯并三嗪类化合物、组合物及其应用
|
CN110776512A
(zh)
|
2019-11-28 |
2020-02-11 |
成都傲飞生物化学品有限责任公司 |
一种核苷类似物的制备方法
|
JP7429799B2
(ja)
|
2020-02-18 |
2024-02-08 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス化合物
|
TWI791193B
(zh)
|
2020-02-18 |
2023-02-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
CN111620909B
(zh)
*
|
2020-06-05 |
2022-12-02 |
广东中科药物研究有限公司 |
一种瑞德西韦的前体药物及其制备方法与应用
|